GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.17) per share. This is a 73.44 percent increase over losses of $(0.64) per share from the same period last year.
Why Jim Cramer Says Applied Materials Is ‘Too Good A Company’
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Comstock Resources Inc (NYSE: CRK) is a "very cheap stock."
